HEALTH OF WOMAN. 2017.8(124):27–31; doi 10.15574/HW.2017.124.27  

Bondarenko N. P., Lakatoch W. P., Kostenko O. J., Lakatoch P. W.
A.A. Bogomolets National Medical University, Kiev
Perinatal center of Kiev

Clinical and diagnostic data of 129 cases of parvovirus B19 infection during pregnancy are presented. Serological and virological results ofparvovirus infection examination of pregnant women and fetuses were evaluated. In 50.4% of cases, the main factor ofdiseasetransmissionis physical contact of pregnant woman with children who had infectious erythema.
Parvovirus infection is diagnosed in 27% of casespregnant women at a risk of intrauterine infection during pregnancy. In 38% of pregnant women, the infection is asymptomatic and can be accidentally detected by the method of determining antibodies to parvovirus B19. In 62%cases maternal and fetal symptoms manifest in parvovirus infection during pregnancy.
In 70% of maternal symptoms correlates with fetus symptoms. Diagnosis of transplacental transmission of parvovirus B19 with symptomatic manifestations of infection occurs in 36.4%. The main clinical symptom of fetal parvovirus infection is the development of non-immune hydrop. In the structure of echographic diagnosis of intrauterine anomalies of fetal development, parvovirus infection occurs in 4.7%.
Key words: parvovirus infection, pregnancy, symptomatology, diagnostics.

REFERENCES

1. Matveev VA, Proschaeva NV, Samoylovich EO, Ermolovich MA. 2008. Kliniko-laboratornaya harakteristika V19-parvovirusnoy infektsii. Infektsionnyie bolezni 6;3:33–37.

2. Chiasaka H, Morita Е, Yaegashi N, Sugamura K. 2003, Nov-Dec. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol. 13(6):347–59.

3. De Jong EP, Walther FJ, Kroes AC, Oepkes D. 2011. ParvovirusB19 infection in pregnancy new insights and management. Prenatal Diagn 31:419–25. https://doi.org/10.1002/pd.2714; PMid:21351281

4. Dijkmans AC, de Jong EP, Dijkmans BA, Loprion E, Vosses A, Walther FJ et al. 2012. Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol 24:95–101. https://doi.org/10.1097/GCO.0b013e3283505a9d; PMid:22249146.

5. Enders M, Weidner A, Zoellner I, Searle K, Enders G. 2004. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy:prospective evaluation of 1018 cases. Prenat Diagn 24:513–8. https://doi.org/10.1002/pd.940.

6. Harger JH, Adler SP, Koch WC, Harger GF. 1988. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risk and symptoms. Obstet Gynicol 91:413–30. https://doi.org/10.1016/S0029-7844(97)00701-1

7. Seve P, Ferry T, Charhon A. 2004, Oct. Systemic manifestations of Parvovirus B19 infections. Rev Med Interne. 25(10):740–51. https://doi.org/10.1016/j.revmed.2004.02.026; PMid:15471600

8. Ziyaeyan M, Rasouli M, Alborzi A. 2005, Apr. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women and their neonates in Shiraz, Iran. Jpn J Infect Dis. 58(2):95–7. PMid:15858287

9. Tohoku J. 2006, Aug. Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Exp Med. 209(4):277–83.

10. Jin Xu, MD, Thomas C Raff, MD, Nabil S Muallem, MD and George A Neubert, MD. 2003, January- February. Hydrops Fetalis Secondary to Parvovirus B19Infections. JABFP. 16;1:63–68. https://doi.org/10.3122/jabfm.16.1.63; PMid:12583652

11. Joan Crane, MD, St John’s NL William Mundle. Parvovirus B19 Infection in Pregnancy. J Obstet Gynaecol Can 2014; 36(12): 1107–1116. https://doi.org/10.1016/S1701-2163(15)30390-X